Bulletin Archive
This archived information is dated to the 2008-09 academic year only and may no longer be current.
For currently applicable policies and information, see the current Stanford Bulletin.
This archived information is dated to the 2008-09 academic year only and may no longer be current.
For currently applicable policies and information, see the current Stanford Bulletin.
Primarily for graduate students; undergraduates may enroll with consent of instructor.
NSUR 261. Principles and Practice of Stem Cell Engineering
(Same as BIOE 261.) Quantitative models used to characterize incorporation of new cells into existing tissues emphasizing pluripotent cells such as embryonic and neural stem cells. Molecular methods to control stem cell decisions to self-renew, differentiate, die, or become quiescent. Practical, industrial, and ethical aspects of stem cell technology application. Final projects: team-reviewed grants and business proposals.
3 units, Aut (Deisseroth, K; Palmer, T)
NSUR 278A. From Science to Business: Innovation in Neurologic Disease Beyond Neurosurgery
For medical, business, and engineering students. The process of innovation and company building in the medical field, emphasizing the neurosciences. Overview of neurological diseases; business and regulatory aspects of device and biotech product development. Guest speakers on healthcare entrepreneurship. Venture capital and entrepreneurial mentors guide interdisciplinary student teams in evaluating a solution to an unmet clinical need or a project within a biotech company. May be taken for 2 units without the team project.
2-4 units, alternate years, not given this year
NSUR 278B. Independent Study on Healthcare Innovation and Entrepreneurship
Continuation of NSUR 278A for students wishing to work on actual strategy and implementation of their idea developed in 278A or, more generally, for students who wish to develop a strategic plan for a specific healthcare (drug or device) venture.
2-4 units, Aut (Kallmeyer, V; Steinberg, G), Win (Kallmeyer, V; Steinberg, G), Spr (Kallmeyer, V; Steinberg, G), Sum (Kallmeyer, V)
NSUR 279. Concepts in Drug Delivery and Drug Device Combinations
Open to all graduate students. Issues relating to drug-device combination products, including review of recently approved products such as cardiac stent), and development, regulatory, and reimbursement issues. Emphasis is on market evaluation, product development, and regulatory strategies. Lecture only for 2 units; project for 4 units.
2-4 units, Win (Kallmeyer, V), alternate years, not given next year
NSUR 299. Directed Reading in Neurosurgery
Prerequisite: consent of instructor.
1-18 units, Aut (Staff), Win (Staff), Spr (Staff), Sum (Staff)
© Stanford University - Office of the Registrar. Archive of the Stanford Bulletin 2008-09. Terms of Use | Copyright Complaints